Polianta Ltd’s Labcorp LH Stock Holding History

Polianta Ltd’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,751	Closed	-$1.18M	–	80
2020 Q4	$1.18M	Buy	+6,751	New	+$1.17M	0.65%	49

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Polianta Ltd's LH Position: Q1 2021 in Review

Polianta Ltd sold out of Labcorp (LH) in Q1 2021, closing a stake of 6,751 shares — an estimated $1.18M sold.

Polianta Ltd first reported a position in LH in Q4 2020 and held it in 1 quarter. The position peaked at $1.18M in Q4 2020. 920 funds tracked by Wall St. Rank hold LH as of Q1 2021.

Polianta Ltd reported no remaining Labcorp position as of Q1 2021 after selling out during the quarter.
Polianta Ltd sold 6,751 Labcorp shares in Q1 2021, an estimated $1.18M.
Polianta Ltd first reported a position in Labcorp in Q4 2020 and held it in 1 quarter.
Polianta Ltd's Labcorp position peaked at $1.18M in Q4 2020.
920 funds tracked by Wall St. Rank held Labcorp as of Q1 2021.

Based on Polianta Ltd's 13F filing for Q1 2021, filed 14 Apr 2021.